1st Feb 2021 07:00
1 February 2021
RTW Venture Fund Limited
(the "Company")
Notice of Change of Administrator, Company Secretary & Registered Office
The Company announces that effective 31 January 2021 it has appointed Elysium Fund Management Limited to serve as the Company's Administrator and Company Secretary, and Morgan Stanley Fund Services USA LLC to serve as the Company's Sub-Administrator.
Elysium's office and the Company's Registered Office is situated at:
1st Floor, Royal Chambers, St Peter Port, Guernsey GY1 3JX
For further information, please contact:
RTW Investments, LP +1 (646) 343 9280
Stephanie Sirota, Chief Business Officer
Alexandra Taracanova, PhD, Director of Investor Relations
Julia Enright, Senior Business Development Associate
Elysium Fund Management Limited +44 (0) 14 8181 0100
Joanna Duquemin Nicolle, Chief Executive Officer
Sadie Morrison, Managing Director
Morgan Stanley Fund Services USA LLC +1 (914) 225 8885
J.P. Morgan Cazenove +44 (0) 20 7742 4000
William Simmonds
Jérémie Birnbaum
James Bouverat (Sales)
Barclays +44 (0) 20 7623 2323
Tom Swerling
Andrew Tusa
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading US healthcare investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more information.
Related Shares:
Rtw Biotech